Showing results (291-300 of 2,280) with videos related to

Sort By:
Pageof 228
HIV Medicine|October 17, 2013
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohortA Kasapovic, C Boesecke, C Schwarze-Zander, et al.
HIV Medicine|November 10, 2015
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive personsL Ryom, C Boesecke, V Gisler, et al.
HIV Medicine|August 18, 2009
Emergency department utilization among HIV-infected patients in a multisite multistate studyJ S Josephs, J A Fleishman, P T Korthuis, et al.
HIV Medicine|May 27, 2010
'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patientsN Bourgeois, P Bastien, J Reynes, et al.
HIV Medicine|May 27, 2010
The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-upH Carsenti-Dellamonica, H Saïdi, M Ticchioni, et al.
HIV Medicine|March 14, 2007
Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and MontenegroD O Jevtović, D Salemović, J Ranin, et al.
HIV Medicine|March 14, 2007
Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in UgandaS R Penzak, G Kabuye, P Mugyenyi, et al.
HIV Medicine|June 15, 2007
Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver diseaseM K Osborn, J L Guest, D Rimland
HIV Medicine|June 15, 2007
Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapyS A Riddler, X Li, H Chu, et al.
HIV Medicine|June 15, 2007
Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccineS D Shafran, L D Mashinter, A Lindemulder, et al.
Pageof 228